Asia

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Asia Analysis

Industry Trend Analysis - Evestra Agreement Will Boost Glenmark's Complex Generics Capabilities - MAY 2017

Although Glenmark Pharmaceuticals does not consider female healthcare to be a central market for it, the US as a regional market is essential, and this agreement with Evestra will act to further boost Glenmark's US sales. It is a long-term agreement, with a US ANDA filing for the vaginal ring not anticipated until FY19. Although not a primary focus under Glenmark's strategic blueprint, Evestra'...

READ FULL ARTICLE...

Industry Trend Analysis - Trump's Policies To Affect The Development Of Region's Pharmaceutical Sectors - APR 2017

Acts undertaken by US President Donald Trump will shape the Asia Pacific's pharmaceutical sectors. The withdrawal of the US from the Trans-Pacific Partnership is particularly significant, passing up an opportunity to introduce strong intellectual property protections which would have had ramifications beyond the original seven Asia Pacific member states. Trump's push to encourage the domestic...

READ FULL ARTICLE...